Drugmakers Turn to AI for Drug Development Amid US Tariff Uncertainty Pharmaceutical executives are increasingly turning to artificial intelligence (AI) as a key tool in accelerating drug development processes. The…
Artificial IntelligenceB2B Trade PlatformPharmaceuticals
